Your browser doesn't support javascript.
loading
Prognostic significance of MST1R dysregulation in renal cell tumors.
Pires-Luís, Ana S; Vieira-Coimbra, Márcia; Ferreira, Maria João; Ramalho-Carvalho, João; Costa-Pinheiro, Pedro; Antunes, Luís; Dias, Paula C; Lobo, Francisco; Oliveira, Jorge; Graça, Inês; Henrique, Rui; Jerónimo, Carmen.
Afiliação
  • Pires-Luís AS; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of PortoPorto, Portugal; Department of Pathology - Portuguese Oncology Institute of PortoPorto, Portugal.
  • Vieira-Coimbra M; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of PortoPorto, Portugal; Department of Pathology - Portuguese Oncology Institute of PortoPorto, Portugal.
  • Ferreira MJ; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of Porto Porto, Portugal.
  • Ramalho-Carvalho J; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of Porto Porto, Portugal.
  • Costa-Pinheiro P; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of Porto Porto, Portugal.
  • Antunes L; Department of Epidemiology - Portuguese Oncology Institute of Porto Porto, Portugal.
  • Dias PC; Department of Pathology - Portuguese Oncology Institute of Porto Porto, Portugal.
  • Lobo F; Department of Urology - Portuguese Oncology Institute of Porto Porto, Portugal.
  • Oliveira J; Department of Urology - Portuguese Oncology Institute of Porto Porto, Portugal.
  • Graça I; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of Porto Porto, Portugal.
  • Henrique R; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of PortoPorto, Portugal; Department of Pathology - Portuguese Oncology Institute of PortoPorto, Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS)
  • Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of The Portuguese Oncology Institute of PortoPorto, Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of PortoPorto, Portugal.
Am J Cancer Res ; 6(8): 1799-811, 2016.
Article em En | MEDLINE | ID: mdl-27648366
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article